Toronto's Proteocyte launches its Straticyte oral cancer diagnostic into US market
Proteocyte Diagnostics launches Straticyte™ to US market at AAOMS Annual Meeting
Last week Proteocyte Diagnostics launched Straticyte at the American Association of Oral Maxillofacial Surgeons 98th Annual Meeting. Straticyte was featured as a new product to over 4000 attendees including 1500 Oral Maxillofacial Surgeons. Proteocyte Diagnostics also presented a poster outlining Straticyte's capability to advance diagnostics for oral precancer and exhibited in the multiday tradeshow.
Join in on the conversation with Zayna Khayat when you subscribe to Toronto Health.